Correlation Between Ocuphire Pharma and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Ocuphire Pharma and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocuphire Pharma and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ocuphire Pharma and Mereo BioPharma Group, you can compare the effects of market volatilities on Ocuphire Pharma and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocuphire Pharma with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocuphire Pharma and Mereo BioPharma.
Diversification Opportunities for Ocuphire Pharma and Mereo BioPharma
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Ocuphire and Mereo is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Ocuphire Pharma and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Ocuphire Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocuphire Pharma are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Ocuphire Pharma i.e., Ocuphire Pharma and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Ocuphire Pharma and Mereo BioPharma
Given the investment horizon of 90 days Ocuphire Pharma is expected to under-perform the Mereo BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, Ocuphire Pharma is 1.09 times less risky than Mereo BioPharma. The stock trades about -0.02 of its potential returns per unit of risk. The Mereo BioPharma Group is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 80.00 in Mereo BioPharma Group on August 29, 2024 and sell it today you would earn a total of 260.00 from holding Mereo BioPharma Group or generate 325.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.56% |
| Values | Daily Returns |
Ocuphire Pharma vs. Mereo BioPharma Group
Performance |
| Timeline |
| Ocuphire Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Mereo BioPharma Group |
Ocuphire Pharma and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ocuphire Pharma and Mereo BioPharma
The main advantage of trading using opposite Ocuphire Pharma and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocuphire Pharma position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| Ocuphire Pharma vs. Reviva Pharmaceuticals Holdings | Ocuphire Pharma vs. Protalix Biotherapeutics | Ocuphire Pharma vs. Eyepoint Pharmaceuticals | Ocuphire Pharma vs. Sellas Life Sciences |
| Mereo BioPharma vs. Eliem Therapeutics | Mereo BioPharma vs. Scpharmaceuticals | Mereo BioPharma vs. Milestone Pharmaceuticals | Mereo BioPharma vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |